Literature DB >> 22615383

Oncogene-mediated alterations in chromatin conformation.

David S Rickman1, T David Soong, Benjamin Moss, Juan Miguel Mosquera, Jan Dlabal, Stéphane Terry, Theresa Y MacDonald, Joseph Tripodi, Karen Bunting, Vesna Najfeld, Francesca Demichelis, Ari M Melnick, Olivier Elemento, Mark A Rubin.   

Abstract

Emerging evidence suggests that chromatin adopts a nonrandom 3D topology and that the organization of genes into structural hubs and domains affects their transcriptional status. How chromatin conformation changes in diseases such as cancer is poorly understood. Moreover, how oncogenic transcription factors, which bind to thousands of sites across the genome, influence gene regulation by globally altering the topology of chromatin requires further investigation. To address these questions, we performed unbiased high-resolution mapping of intra- and interchromosome interactions upon overexpression of ERG, an oncogenic transcription factor frequently overexpressed in prostate cancer as a result of a gene fusion. By integrating data from genome-wide chromosome conformation capture (Hi-C), ERG binding, and gene expression, we demonstrate that oncogenic transcription factor overexpression is associated with global, reproducible, and functionally coherent changes in chromatin organization. The results presented here have broader implications, as genomic alterations in other cancer types frequently give rise to aberrant transcription factor expression, e.g., EWS-FLI1, c-Myc, n-Myc, and PML-RARα.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615383      PMCID: PMC3384175          DOI: 10.1073/pnas.1112570109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Sensitivity of multiple color spectral karyotyping in detecting small interchromosomal rearrangements.

Authors:  Y S Fan; V M Siu; J H Jung; J Xu
Journal:  Genet Test       Date:  2000

Review 2.  Regulation of Ets function by protein - protein interactions.

Authors:  R Li; H Pei; D K Watson
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

3.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

Authors:  Qianben Wang; Wei Li; X Shirley Liu; Jason S Carroll; Olli A Jänne; Erika Krasnickas Keeton; Arul M Chinnaiyan; Kenneth J Pienta; Myles Brown
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

4.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

5.  Integrative molecular concept modeling of prostate cancer progression.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Xuhong Cao; Lei Wang; Saravana M Dhanasekaran; Shanker Kalyana-Sundaram; John T Wei; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

6.  Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions.

Authors:  Zhihu Zhao; Gholamreza Tavoosidana; Mikael Sjölinder; Anita Göndör; Piero Mariano; Sha Wang; Chandrasekhar Kanduri; Magda Lezcano; Kuljeet Singh Sandhu; Umashankar Singh; Vinod Pant; Vijay Tiwari; Sreenivasulu Kurukuti; Rolf Ohlsson
Journal:  Nat Genet       Date:  2006-10-08       Impact factor: 38.330

7.  Multicolor spectral karyotyping of human chromosomes.

Authors:  E Schröck; S du Manoir; T Veldman; B Schoell; J Wienberg; M A Ferguson-Smith; Y Ning; D H Ledbetter; I Bar-Am; D Soenksen; Y Garini; T Ried
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

8.  Capturing chromosome conformation.

Authors:  Job Dekker; Karsten Rippe; Martijn Dekker; Nancy Kleckner
Journal:  Science       Date:  2002-02-15       Impact factor: 47.728

9.  Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.

Authors:  Uma R Chandran; Changqing Ma; Rajiv Dhir; Michelle Bisceglia; Maureen Lyons-Weiler; Wenjing Liang; George Michalopoulos; Michael Becich; Federico A Monzon
Journal:  BMC Cancer       Date:  2007-04-12       Impact factor: 4.430

10.  Active genes dynamically colocalize to shared sites of ongoing transcription.

Authors:  Cameron S Osborne; Lyubomira Chakalova; Karen E Brown; David Carter; Alice Horton; Emmanuel Debrand; Beatriz Goyenechea; Jennifer A Mitchell; Susana Lopes; Wolf Reik; Peter Fraser
Journal:  Nat Genet       Date:  2004-09-07       Impact factor: 38.330

View more
  73 in total

Review 1.  Genomic rearrangements in prostate cancer.

Authors:  Christopher E Barbieri; Mark A Rubin
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

2.  multiHiCcompare: joint normalization and comparative analysis of complex Hi-C experiments.

Authors:  John C Stansfield; Kellen G Cresswell; Mikhail G Dozmorov
Journal:  Bioinformatics       Date:  2019-09-01       Impact factor: 6.937

Review 3.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 4.  Recurrent rearrangements in prostate cancer: causes and therapeutic potential.

Authors:  Nicole M White; Felix Y Feng; Christopher A Maher
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

5.  Genomic hallmarks of localized, non-indolent prostate cancer.

Authors:  Michael Fraser; Veronica Y Sabelnykova; Takafumi N Yamaguchi; Lawrence E Heisler; Julie Livingstone; Vincent Huang; Yu-Jia Shiah; Fouad Yousif; Xihui Lin; Andre P Masella; Natalie S Fox; Michael Xie; Stephenie D Prokopec; Alejandro Berlin; Emilie Lalonde; Musaddeque Ahmed; Dominique Trudel; Xuemei Luo; Timothy A Beck; Alice Meng; Junyan Zhang; Alister D'Costa; Robert E Denroche; Haiying Kong; Shadrielle Melijah G Espiritu; Melvin L K Chua; Ada Wong; Taryne Chong; Michelle Sam; Jeremy Johns; Lee Timms; Nicholas B Buchner; Michèle Orain; Valérie Picard; Helène Hovington; Alexander Murison; Ken Kron; Nicholas J Harding; Christine P'ng; Kathleen E Houlahan; Kenneth C Chu; Bryan Lo; Francis Nguyen; Constance H Li; Ren X Sun; Richard de Borja; Christopher I Cooper; Julia F Hopkins; Shaylan K Govind; Clement Fung; Daryl Waggott; Jeffrey Green; Syed Haider; Michelle A Chan-Seng-Yue; Esther Jung; Zhiyuan Wang; Alain Bergeron; Alan Dal Pra; Louis Lacombe; Colin C Collins; Cenk Sahinalp; Mathieu Lupien; Neil E Fleshner; Housheng H He; Yves Fradet; Bernard Tetu; Theodorus van der Kwast; John D McPherson; Robert G Bristow; Paul C Boutros
Journal:  Nature       Date:  2017-01-09       Impact factor: 49.962

6.  A computational strategy to adjust for copy number in tumor Hi-C data.

Authors:  Hua-Jun Wu; Franziska Michor
Journal:  Bioinformatics       Date:  2016-08-16       Impact factor: 6.937

Review 7.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.

Authors:  Christopher Weier; Michael C Haffner; Timothy Mosbruger; David M Esopi; Jessica Hicks; Qizhi Zheng; Helen Fedor; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Pathol       Date:  2013-06       Impact factor: 7.996

9.  p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

Authors:  Christoph Burdelski; Tatsiana Dieckmann; Asmus Heumann; Claudia Hube-Magg; Martina Kluth; Burkhard Beyer; Thomas Steuber; Raisa Pompe; Markus Graefen; Ronald Simon; Sarah Minner; Maria Christina Tsourlakis; Christina Koop; Jakob Izbicki; Guido Sauter; Till Krech; Thorsten Schlomm; Waldemar Wilczak; Patrick Lebok
Journal:  Tumour Biol       Date:  2016-07-21

10.  Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.

Authors:  Deepak Babu; Melissa J Fullwood
Journal:  Nat Genet       Date:  2017-08-30       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.